The research work concern the effect of Mr. Mahendra Kumar Trivedi’s biofield energy treatment (The Trivedi Effect^®) on drug resistant tuberculosis, already has been published in an International peer-reviewed journal entitle “Mycobacterial Diseases”. Tuberculosis (TB), caused by Mycobacterium tuberculosis, primarily affects the lung. It may spread to other organs. It is a bacterial infection spread by inhaling the tiny droplets from the coughs or sneezes of an infected person. Typical symptoms include a persistent cough – sometimes with phlegm that is bloody, weight loss, night sweats, high temperature (fever), tiredness and fatigue, loss of appetite and swellings. Global tuberculosis control is facing major challenges now a days. Multidrug resistance of Mycobacterium tuberculosis (MDR-TB) and extensively drug-resistant TB (XDR-TB) have recently become a serious public health issue. Currently, available treatment directly observed treatment short course (DOTS) regimen for both cases are not successful to some extent due to some drawbacks. In this situation, world health communities are looking for some kind of alternative treatment approach. Based on the results of this experiment, rifampicin, ethambutol and streptomycin in biofield treated samples showed increased susceptibility as 3.33%, 3.33% and 400.6%, respectively, as compared to the control in extensive drug resistance (XDR) strains. Pyrazinamide showed 300% susceptibility as compared to control in multidrug resistance (MDR) strains. Moreover, the resistance pattern of treated group was reduced in case of isoniazide (26.7%), rifampicin (27.6%), pyrazinamide (31.4%), ethambutol (33.43%) and streptomycin (41.3%) as compared to the untreated group of XDR strains. Significant reduction was also observed in minimum inhibitory concentration (MIC) values of linezolid and tobramycin. In conclusion, Mr. Trivedi’s biofield treatment can able to improve the sensitivity of antitubercular drugs and an alternative therapeutic approach against resistance strains of Mycobacterium.

Here is the link to this wonderful ground breaking research: http://www.omicsonline.org/open-access/an-impact-of-biofield-treatment-antimycobacterial-susceptibility-potential-using-bactec-460mgittb-system-2161-1068-1000189.php?aid=59486